A Treatment Option for Certain Patients With Resectable Non-Small Cell Lung Cancer (NSCLC)

Industry Speaker(s)

• 

  Hari B. Keshava, MD MS FACS

  HS Clinical Assistant Professor
  University of California, Irvine
  Los Angeles, California, United States

  Disclosure(s): AstraZeneca (Any division): Consultant (Ongoing), Speaker (Ongoing)